CLINICAL_TRIALS
trial_result
· 2020-06-02
Clinical Trial Update: Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines [Phase 4]
Summary
Phase 4 trial investigating the effect of anti-IL-5 therapy on sputum cells and cytokines in asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: KU Leuven | Conditions: Asthma | Phase 4 | Status: COMPLETED